DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Product Portfolio for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices 2017 - MedFolio" report to their offering.
Stereotaxy has become the standard of care in neurosurgery therefore the market for stereotactic systems is saturated, limiting growth in market value. Innovative technology and updated features and software will be required to encourage growth. New competitors have entered the neuromodulation market which will drive competitive pressure in technological advancement and pricing.
This will have the greatest impact on the spinal cord stimulator and deep brain stimulator markets. One of the major market drivers for neurological devices is the patient and physicians demand for minimally invasive procedures.
This has been driving the growth in interventional neuroradiology and neuroendoscopy. This has led to procedural growth in endovascular embolization treatments and a decline in aneurysm clipping procedures treatments. Access devices are becoming increasingly technologically advanced and various embolization devices have been released in recent years.
One of the major emerging trends is the growth of mechanical thrombectomy devices for ischemic stroke. These devices extend the window for treatment of patients compared to medical therapy alone and can provide dramatically improved clinical outcomes.
Key Topics Covered:
Table Of Contents I
List Of Figures Xi
List Of Charts Xvii
U.S. Neuromodulation, Neurovascular, Neurosurgical And Monitoring Device Market Overview
Procedure Codes Investigated
Key Report Updates
St. Jude Medical
Codman & Shurtleff
For more information about this report visit http://www.researchandmarkets.com/research/h4j43t/us_product